Note: Ingredients listed on restricted chemical lists
EC/CAS
225-768-6/5064-31-3
Name of the chemical
Trisodium nitrilotriacetate
Concentration
0.1-<0.5
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
<0.1
General Information
Version
1.0
Revision date
2023-03-15
Product name
Wickes Clean Spirit
1.2.2. Uses advised against
thinning oil based paints. Reason product is water based and will not work
Manufacturer Name
Bartoline Limited
Emergency telephone
+44(0)1482 678710
Icons in SDS
Company Information
company name
Bartoline Limited
e-mail address of the competent person responsible for the Safety Data Sheet
infor@bartoline.co.uk
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Precautionary statements
P102 - Keep out of reach of children. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P302+P352 – IF ON SKIN: Wash with plenty of water. P332+P313 - If skin irritation occurs: Get medical advice/attention Extra labelling phrases : Avoid prolonged contact with skin. Where prolonged contact with skin is unavoidable wear rubber gloves. Not recommended for thinning of oil-based paints, white spirit should be used for this purpose. Keep out of direct sunlight. EU Limit for this product (CatB/a) is 850 g/L. This product contains max 63 g/L VOC. To avoid the risk of spillage always ensure the cap is secure and the container is held upright during transportation and storage. Contains less than 5%: NTA (nitrilotriacetic acid) and salts thereof, non-Ionic surfactants.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
